Top

Published in:

Open Access 01-11-2009 | Hepatobiliary-Pancreas

Parametric exploration of the liver by magnetic resonance methods

Author: Paul E. Sijens

Published in: European Radiology | Issue 11/2009

Abstract

MRI, as a completely noninvasive technique, can provide quantitative assessment of perfusion, diffusion, viscoelasticity and metabolism, yielding diverse information about liver function. Furthermore, pathological accumulations of iron and lipids can be quantified. Perfusion MRI with various contrast agents is commonly used for the detection and characterization of focal liver disease and the quantification of blood flow parameters. An extended new application is the evaluation of the therapeutic effect of antiangiogenic drugs on liver tumours. Novel, but already widespread, is a histologically validated relaxometry method using five gradient echo sequences for quantifying liver iron content elevation, a measure of inflammation, liver disease and cancer. Because of the high perfusion fraction in the liver, the apparent diffusion coefficients strongly depend on the gradient factors used in diffusion-weighted MRI. While complicating analysis, this offers the opportunity to study perfusion without contrast injection. Another novel method, MR elastography, has already been established as the only technique able to stage fibrosis or diagnose mild disease. Liver fat content is accurately determined with multivoxel MR spectroscopy (MRS) or by faster MRI methods that are, despite their widespread use, prone to systematic error. Focal liver disease characterisation will be of great benefit once multivoxel methods with fat suppression are implemented in proton MRS, in particular on high-field MR systems providing gains in signal-to-noise ratio and spectral resolution.

Tian JL, Zhang JS (2006) Hepatic perfusion disorders: etiopathogenesis and related diseases. World J Gastroenterol 12:3265–3270PubMed

Lupescu IG, Grasu M, Capşa R, Pitrop A, Georgescu SA (2006) Hepatic perfusion disorders: computer-tomographic and magnetic resonance imaging. J Gastrointestin Liver Dis 15:273–279PubMed

Karabulut N, Elmas N (2006) Contrast agents used in MR imaging of the liver. Diagn Interv Radiol 12:22–30PubMed

Abdullah SS, Pialat JB, Wiart M, Duboeuf F, Mabrut J-Y, Bancel B, Rode A, Ducerf C, Baulieux J, Berthezene Y (2008) Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI. J Magn Reson Imaging 28:390–395PubMed

Miyazaki K, Collins DJ, Walker-Samuel S, Taylor JN, Padhani AR, Leach MO, Koh D-M (2008) Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor. Eur Radiol 18:1414–1421PubMed

Hagiwara M, Rusinek H, Lee VS, Lasoda M, Bannan MA, Krinsky GA, Taouli B (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience. Radiology 246:926–934PubMed

Inoue T, Kudo M, Hatanaka K, Takahashi S, Kitai S, Ueda T, Ishikawa E, Hagiwara S, Minami Y, Chung H, Ueshima K, Maekawa K (2008) Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced untrasonography with Sonazoid. Oncology 75(suppl 1):48–54PubMed

Finch CA, Bellotti V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, Huebers HA (1986) Plasma ferritin concentration as a diagnostic tool. Clinical review. West J Med 145:657–663

Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213–1216PubMed

10.

Matzner Y, Konijn AM, Hershko C (1980) Serum ferritin in hematologic malignancies. Am J Hematol 9:13–22PubMed

11.

Lee MH, Means RT Jr (1995) Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med 98:566–571PubMed

12.

Drakoniaki E, Papakonstantinou O, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N (2005) Adrenal glands in beta-thalamassic major: magnetic resonance (MR) imaging features and correlation with iron stores. Eur Radiol 15:2462–2468

13.

Kreeftenberg HG Jr., Mooyaart EL, Huizenga JR, Sluiter WJ (2000) Quantification of liver iron concentration with magnetic resonance imaging by combining T1-, T2- weighted spin echo sequences and a gradient echo sequence. Neth J Med 56:133–137PubMedCrossRef

14.

St Pierre TG (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105:855–8618PubMed

15.

Argyropoulou MI, Bonkovsky HL (1999) Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 212:227–234

16.

Bonkovsky HL (1999) Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 212:227–234PubMed

17.

Gandon Y, Olivié D, Guyader D, Aubé C, Oberta F, Sebille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363:357–362PubMed

18.

Olthof A, Sijens P, Kreeftenberg H, Kappert P, Irwan R, van der Jagt E, Oudkerk M (2007) Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging 25:228–231PubMed

19.

Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M (2007) Comparison of effects of different long-term iron chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. Int J Hematol 86:385–389PubMed

20.

Lam WWM, Au WY, Chu WCW, Tam S, Ha SY, Pennel DJ (2008) One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging 28:29–33PubMed

21.

Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia- Bengoechea M, Barrio J, Mujica F, Recondo JA (2004) MR quantification of hepatic iron concentration. Radiology 230:479–484PubMed

22.

Laine F, Reymann JM, Morel F, Langouet S, Perrin M, Guillygomarc’h A, Brissot P, Turmel V, Mouchel C, Pape D, Bellissant E, Deugnier Y (2006) Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial. Aliment Pharmacol Ther 24:1207–1213PubMed

23.

Papakonstantinou O, Maris TG, Kostaridou S, Ladis V, Vasiliadou A, Gourtsoyiannis NC (2005) Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C. AJR Am J Roentgenol 185:219–224PubMed

24.

Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, van der Jagt E, Oudkerk M (2008) Non-invasive liver iron concentration measurement by MRI: Comparison of two validated protocols. Eur J Radiol. doi:10.1016/j.ejrad.2008.02.008

25.

Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505PubMed

26.

Thoeny HC, De Keyzer F, Boesch C, Hermans R (2004) Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 20:786–790PubMed

27.

Yeung DKW, Wong SYS, Griffith JF, Lau EMC (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222–228PubMed

28.

Luciani A, Vignaud A, Cavet M, Van Nhieu JT, Mallat A, Ruel L, Laurent A, Deux JF, Brugieres P, Rahmouni A (2008) Liver cirrhosis:intravoxel incoherent motion MR imaging. Radiology 249:891–899PubMed

29.

Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, Watanabe H, Shiratori Y, Onezuka M, Moriyama N (2008) Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 28:691–697PubMed

30.

Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 219:617–623

31.

Koh DM, Scurr E, Collins DJ, Pirgon A, Kanber B, Karanjia N, Brown G, Leach MO, Husband JE (2006) Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol 16:1898–1905PubMed

32.

Sun XJ, Quan XY, Huang FH, Xu YK (2005) Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 11:6535–6537PubMed

33.

Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B, Stemmer A, Ganter C, Rummeny EJ (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485PubMed

34.

Inan N, Arslan A, Akansel G, Anik Y, Sarisoy TH, Ciftci E, Dimerci A (2007) Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 189:1031–1036PubMed

35.

Girometti R, Furlan A, Esposito G, Bazzocchi M, Como G, Soldano F, Isola M, Toniutto P, Zuiani C (2008) Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 28:411–419PubMed

36.

Kwee TC, Takahara T, Koh DM, Nievelstein RA, Kuijten PR (2008) Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 28:1141–1148PubMed

37.

Chen YC, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, Hsu JS, Liu GC (2006) Early response of hepatocellular carcinoma to transcatheter arterial chemoembolisation: choline levels and MR diffusion constants—initial experience. Radiology 239:448–456PubMed

38.

Kamel IR, Liapi E, Reyes DK, Zuhurak M, Bleumke DA, Geschwind JFH (2009) Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 250:466–473PubMed

39.

Gourtsoyianni S, Papanicolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N (2008) Respiratory gated diffusion weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 18:486–492PubMed

40.

Hoolingsworth KG, Lomas DJ (2006) Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 19:231–235

41.

Parker KJ, Huang SR, Musulin RA, Lerner RM (1990) Tissue response to mechanical vibration s for sonoelasticity imaging. Ultrasound Med Biol 16:241–246PubMed

42.

Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269:1854–1857PubMed

43.

Plewes DB, Betty I, Urchuk SN, Soutar I (1995) Visualizing tissue compliance with MR imaging. J Magn Reson imaging 5:733–738PubMed

44.

Rouvière O, Yin M, Dresner MA, Rossman PJ, Burgart LJ, Fidler JL, Ehman RL (2006) MR elasticity of the liver: preliminary results. Radiology 240:440–448PubMed

45.

Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, Horsmans Y, Van Beers BE (2006) Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 19:173–179PubMed

46.

Klatt D, Asbach P, Rump J, Papazoglou S, Somasundaram M, Modrow J, Braun J, Sack I (2006) In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol 41:841–848PubMed

47.

Yin M, Woollard J, Wang X, Torres VE, Harris PC, Ward CJ, Glaser KJ, Manduca A, Ehman RL (2007) Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 58:346–353PubMed

48.

Klatt D, Hamhaber U, Asbach P, Braun J, Sack I (2007) Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity. Phys Med Biol 52:7281–7294PubMed

49.

Salameh N, Peeters F, Sinkus R, Abarca-Quinones J, Annet L, ter Beek LC, Leclercq I, Van Beers BE (2007) Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 26:956–962PubMed

50.

Rump J, Klatt D, Braun J, Warmuth C, Sack I (2007) Fractional encoding of harmonic motions in MR elastography. Magn Reson Med 57:388–395PubMed

51.

Asbach P, Klatt D, Hamhaber U, Braun J, Somasundaram R, Hamm B, Sack I (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373–379PubMed

52.

Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, Peeters F, ter Beek LC, Horsmans Y, Van Beers BE (2007) Liver fibrosis: non-invasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466PubMed

53.

Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL (2007) A preliminary assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213PubMed

54.

Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, Ehman RL (2008) MR elastography of liver tumors: preliminary results. Am J Roentgenol AJR 190:1534–1540

55.

Bonekamp S, Kamel I, Solga S, Clark J (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatology 50:17–35

56.

Adams LA, Sanderson S, Lindor KD, Angulo P (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132–138PubMed

57.

Dam-Larsen S, Franzmann MB, Christoffersen P, Larsen K, Becker U, Bendtsen F (2005) Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol 40:460–467PubMed

58.

Hoyumpa AM Jr, Green HL, Dunn GD, Schenker S (1975) Fatty liver: biochemical and clinical considerations. Am J Dig Dis 20:1142–1170PubMed

59.

Volzke H, Robinson DM, Kleine V, Deutcher R, Hoffmann W, Ludeman W, Schminke U, Kessler C, John U (2005) Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848–1853PubMed

60.

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMed

61.

Szczepaniak LS, Nurenberg P, Leonard D, browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462–E468PubMed

62.

Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G (2004) Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 27:2498–2500PubMed

63.

Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, Jo JY, Yi NJ, Suh KS, Shin KS, Jo SY, Choi BI (2006) Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology 240:117–129

64.

Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308PubMed

65.

Longo R, Ricci C, Masutti F, Vidimari R, Crocé LS, Bercich L, Tiribelli C, Dalla Palma L (1993) Fatty infiltration of the liver. Quantification by ¹H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 4:297–302

66.

Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495PubMed

67.

Sijens PE, Smit GP, Borgdorff MAJ, Kappert P, Oudkerk M (2006) Multiple voxel ¹H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging. J Hepatol 45:851–855PubMed

68.

Irwan R, Edens MA, Sijens PE (2008) Assessment of the variations in fat content in normal liver using a fast quantification MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18:806–813PubMed

69.

Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J (2008) Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 47:1513–1523PubMed

70.

Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153:189–194PubMed

71.

Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology 237:1048–1055PubMed

72.

O’Regan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA (2008) Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T—feasibility. Radiology 247:550–557PubMed

73.

Guiu B, Loffroy R, Cercueil JP, Krause D (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification (letter-to-the-editor). Radiology 249:1081PubMed

74.

Xiang QS (2006) Two-point water-fat imaging with partially opposed-phase (POP) acquisition: an asymmetric Dixon method. Magn Reson Med 56:572–584PubMed

75.

Paltiel Z (1985) Separate water and lipids images obtained by a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 172–173

76.

Patrick JL, Haacke EM, Hahn JE (1985) Water fat separation and chemical shift artefact correction using a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 174–175

77.

Ahn CB, Lee SY, Nalcioglu O, Cho ZH (1986) Spectroscopic imaging by quadrature modulated echo time shifting. Magn Reson Imaging 4:110–111

78.

Xiang QS, An L (1997) Water-fat imaging with direct phase encoding. J Magn Reson Imaging 7:1002–1015PubMed

79.

Cottler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ (2007) Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging 25:743–748

80.

Machan J, Thamer C, Schnoedt B, Stefan N, Haring H-U, Claussen CD, Frische A, Schick F (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized ¹H-MR spectroscopy. Magn Reson Med 55:913–917

81.

Sijens PE, Oudkerk M (2005) Clinical magnetic resonance spectroscopy. Imaging Decis MRI 9:39–48

82.

Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M (1998) Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 16:205–211PubMed

83.

Buchli R, Meier D, Martin E, Boesiger P (1994) Assessment of absolute metabolite concentrations in human tissue by ³¹P MRS in vivo. Magn Reson Med 32:453–458PubMed

84.

Norén B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O (2005) Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 15:148–157PubMed

85.

Cox IJ, Couts GA, Gadian DG, Ghosh P, Sargentoni J, Young IR (1991) Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn Reson Med 17:53–61PubMed

86.

Sijens PE, van Dijk P, Dagnelie PC, Oudkerk M (1995) Non-T1 weighted 31P MR chemical shift imaging of the human liver. Magn Reson Imaging 13:621–628PubMed

87.

Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR (1996) Molar quantitation of hepatic metabolites in vivo proton-decoupled, nuclear Overhauser effect enhanced ³¹P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9:141–155PubMed

88.

Schlemmer H-P, Sawatzki T, Sammet S, Dornacher I, Bachert P, van Kaick G, Waldherr R, Seitz HK (2005) Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled ³¹P magnetic resonance spectroscopy. J Hepatol 42:752–759PubMed

89.

Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21:417–427PubMed

90.

van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WP (1995) ³¹P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 21:443–449PubMed

91.

Dezortova M, Taimr A, Skoch A, Spicak J, Hajek M (2005) Etiology and functional status of liver cirrhosis by ³¹P MR spectroscopy. World J Gastroenterol 11:6926–6931PubMed

92.

Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y-T, Goldin RD, Taylor-Robinson SD (2007) 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. Am J Roentgenol AJR 189:819–823

93.

Norén B, Dahlquist O, Lundberg P, Almer S, Kechagias S, Ekstedt M, Franzèn L, Wirell S, Smedby O (2008) Separation of advanced from mild cirrhosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur Radiol 15:148–157

94.

Lim AKP, Patel N, Hamilton G, Goldin RD, Hajnal JV, Taylor-Robinson SD (2003) Findings at 31P magnetic resonance spectroscopy correlate with histology in chronic hepatitis C virus infection. Hepatology 27:788–794

95.

Sharma R, Sinha S, Danishad KA, Vikram NK, Gupta A, Ahuja V, Jagannathan NR, Pandey RM, Misra A (2009) Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo (³¹P) phosphorus magnetic resonance spectroscopy. Atherosclerosis 203(1):291–297. doi: 10.1016/j.atherosclerosis.2008.06.016 PubMed

96.

Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P (1999) Abnormal liver metabolism in cancer patients detected by ³¹P MR spectroscopy. NMR Biomed 12:535–544PubMed

97.

Leij-Halfwerk S, Dagnelie PC, Kappert P, Oudkerk M, Sijens PE (2000) Decreased hepatic energy and phosphorylation status in the liver of advanced lung cancer patients with weight loss. J Hepatol 32:887–892PubMed

98.

Schmid AI, Chmelik M, Szendroedi J, Krššák M, Brehm A, Moser E, Roden M (2008) Quantitative ATP synthesis in human liver measured by localized ³¹P spectroscopy using the magnetization transfer experiment. NMR Biomed 21:437–443PubMed

99.

Jiang T, Liu S, Xiao XS, Toa XF, Liu GH, Wang JL (2008) Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy. Abdom Imaging. doi:10.1007/s00261-008-9451-1

100.

Orlacchio A, Bolacchi F, Cadioli M, Bergamini A, Cozzolino V, Angelico M, Simonetti G (2008) Evaluation of the severity of chronic hepatitis C with 3-T ¹H-MR spectroscopy. AJR Am J Roentgenol 190:1331–1339PubMed

101.

Roser W, Beckmann N, Wiesman U, Seelig J (1996) Absolute concentration of the hepatic glycogen content in a patient with glycogen storage disease by ¹³C magnetic resonance spectroscopy. Magn Reson Imaging 14:1217–1220PubMed

102.

Tomiyasu M, Obata T, Nishi Y, Nakamoto H, Nonaka H, Takayama Y, Autio J, Ikehira H, Kanno I (2009) Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy. Eur J Radiol. doi:10.1016/j.ejrad.2008.10.019

103.

Wolf W, Albright MJ, Silver MS, Weber H, Reichart U, Sauer R (1987) Fluorine-19 NMR spectroscopic studies of the metabolism of patients undergoing chemotherapy. Magn Reson Imaging 5:165–169PubMed

104.

Li CW, Negendank WG, Padavic–Shaller KA, O’Dwyer PJ, Murphy-Boesch J, Brown TR (1996) Quantitation of 5-fluorouracil catabolism in human liver in vivo by three- dimensional localized ¹⁹F magnetic resonance spectroscopy. Clin Cancer Res 2:339–345PubMed

105.

Semmler W, Bachert-Bauman P, Gückel F, Ermark F, Schlag P, Lorenz WJ, van Kaick G (1990) Real-time follow-up of 5-fluorouracil in the liver of tumor patients by means of F-19 MR spectroscopy. Radiology 174:141–145PubMed

106.

van Laarhoven HWM, Klomp DWJ, Rijpkema M, Kamm YLM, Wegener DJT, Barentz JO, Punt CJA, Heerschap A (2007) Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized ¹⁹F MRS pharmacokinetic studies of 5-fluorouracil. NMR Biomed 20:128–140PubMed

107.

Boesiger P, Buchli R, Meier B, Steinmann B, Gitzelmann R (1994) Changes of liver metabolite concentrations in adults with disorders of fructose metabolism after intravenous fructose by ³¹P magnetic resonance spectroscopy. Pediatr Res 36:436–440PubMed

108.

Dufour JF, Stoupis C, Lazeyras F, Vock P, Terrier F, Reichen J (1992) Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic ³¹phosphorus spectroscopy. Hepatology 15:835–842PubMed

109.

Leij-Halfwerk S, Dagnelie PC, van den Berg JWO Wilson JHP, Sijens PE (2000) Hepatic sugar phosphate levels and rate of gluconeogenesis in lung cancer: simultaneous turnover measurements and ³¹P magnetic resonance spectroscopy in vivo. Clin Sci 98:167–174PubMed

110.

Leij-Halfwerk S, van den Berg JWO, Sijens PE, Wilson JHP, Oudkerk M, Dagnelie PC (2000) Altered hepatic gluconeogenesis during L-alanine infusion in weight losing lung cancer patients as observed by ³¹P MR spectroscopy and turnover measurements. Cancer Res 60:618–623PubMed

111.

Leij-Halfwerk S, Agteresch HJ, Sijens PE, Dagnelie PC (2002) Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo ³¹P magnetic resonance spectroscopy study. Hepatology 35:421–424PubMed

112.

Dagnelie PC, Bell JD, Cox IJ, Menon DK, Sargentoni J, Couts GA, Williams SCR (1993) Effects of fish oil on phospholipid metabolism in human and rat liver studied by ³¹P NMR spectroscopy in vivo and in vitro. NMR Biomed 6:157–162PubMed

113.

Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604PubMed

114.

Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, Mountford CE, Russell P (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 34:417–422PubMed

Title: Parametric exploration of the liver by magnetic resonance methods
Author: Paul E. Sijens
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: European Radiology / Issue 11/2009
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-009-1470-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Parametric exploration of the liver by magnetic resonance methods

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2009

Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography

Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation

Prospectively ECG-triggered high-pitch spiral acquisition for coronary CT angiography using dual source CT: technique and initial experience

Carotid MR angiography with traditional bolus timing: clinical observations and Fourier-based modelling of contrast kinetics

An incidental mass seen at CT coronary angiography (2009: 11a)

Pancreatic portal cavernoma in patients with cavernous transformation of the portal vein: MR findings